Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1411214
This article is part of the Research Topic Precision Medical Imaging for Cancer Diagnosis and Treatment - Vol. II View all 31 articles

Adrenal indeterminate nodules: CT-based radiomics analysis of different machine learning models for predicting adrenal metastases in lung cancer patients

Provisionally accepted
Lixiu Cao Lixiu Cao 1*Haoxuan Yang Haoxuan Yang 2*Huijing Wu Huijing Wu 1,3*Hongbo Zhong Hongbo Zhong 1,3*Haifeng Cai Haifeng Cai 1,3*Yixing Yu Yixing Yu 4*Lei Zhu Lei Zhu 5*Yongliang Liu Yongliang Liu 6*Jingwu Li Jingwu Li 1,3*
  • 1 Tangshan People's Hospital, Tangshan, Hebei Province, China
  • 2 Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China
  • 3 Other, Tangshan, China
  • 4 Department of Radiology, First Affiliated Hospital, Soochow University Medical College, Suzhou, Jiangsu Province, China
  • 5 National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China
  • 6 Department of Neurosurgery, Tangshan People’s Hospital, Tangshan, China

The final, formatted version of the article will be published soon.

    1 Objective There is a paucity of research using different machine learning algorithms for distinguishing between adrenal metastases and benign tumors in lung cancer patients with adrenal indeterminate nodules based on plain and biphasic-enhanced CT radiomics. 2 Materials and Methods This study retrospectively enrolled 292 lung cancer patients with adrenal indeterminate nodules (training dataset, 205 (benign, 96; metastases, 109); testing dataset, 87(benign, 42; metastases, 45)). Radiomics features were extracted from the plain, arterial, and portal CT images, respectively. The independent risk radiomics features selected by least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression (LR) were used to construct the single-phase and combined-phase radiomics models, respectively, by support vector machine (SVM), decision tree (DT), random forest (RF), and LR. The independent clinical-pathological and radiological risk factors for predicting adrenal metastases selected by using univariate and multivariate LR were used to develop the traditional model. The optimal model was selected by ROC curve, and the models’ clinical values were estimated by decision curve analysis (DCA). 3 Results In the testing dataset, all SVM radiomics models showed the best robustness and efficiency, and then RF, LR, and DT models. The combined radiomics model had the best ability in predicting adrenal metastases (AUC=0.938), and then the plain (AUC=0.935), arterial (AUC=0.870), and portal radiomics model (AUC=0.851). Besides, compared to clinical-pathological-radiological model(AUC=0.870), the discriminatory capability of the plain and combined radiomics model were further improved. All radiomics models had good calibration curves and DCA showed the plain and combined radiomics models had more optimal clinical efficacy compared to other models, with the combined radiomics model having the largest net benefit. 4 Conclusions The combined SVM radiomics model can non-invasively and efficiently predict adrenal metastatic nodules in lung cancer patients. In addition, the plain radiomics model with high predictive performance provides a convenient and accurate new method for patients with contraindications in enhanced CT.

    Keywords: Adrenal indeterminate nodules1, radiomics2, Different machine learning algorithms3, Adrenal metastases4, Lung cancer5.

    Received: 02 Apr 2024; Accepted: 25 Oct 2024.

    Copyright: © 2024 Cao, Yang, Wu, Zhong, Cai, Yu, Zhu, Liu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Lixiu Cao, Tangshan People's Hospital, Tangshan, Hebei Province, China
    Haoxuan Yang, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei Province, China
    Huijing Wu, Tangshan People's Hospital, Tangshan, Hebei Province, China
    Hongbo Zhong, Tangshan People's Hospital, Tangshan, Hebei Province, China
    Haifeng Cai, Tangshan People's Hospital, Tangshan, Hebei Province, China
    Yixing Yu, Department of Radiology, First Affiliated Hospital, Soochow University Medical College, Suzhou, 215006, Jiangsu Province, China
    Lei Zhu, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300070, Tianjin Municipality, China
    Yongliang Liu, Department of Neurosurgery, Tangshan People’s Hospital, Tangshan, China
    Jingwu Li, Tangshan People's Hospital, Tangshan, Hebei Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.